Literature DB >> 23174621

Activated thrombin-activatable fibrinolysis inhibitor (TAFIa) levels are decreased in patients with trauma-induced coagulopathy.

T Lustenberger1, B Relja, B Puttkammer, E C Gabazza, E Geiger, Y Takei, J Morser, I Marzi.   

Abstract

INTRODUCTION: The thrombin-activatable fibrinolysis inhibitor (TAFI) is a potent inhibitor of fibrinolysis. However, the time course of TAFI and its activated form (TAFIa) following trauma, in particular in patients suffering trauma-induced coagulopathy, has been poorly examined.
METHODS: A total of 26 severely injured trauma patients were prospectively enrolled. TAFI and TAFIa levels were measured upon arrival and through hospital days one to 10. Trauma-induced coagulopathy was defined as elevated international normalized ratio (INR), and/or prolonged activated partial thromboplastin time (aPTT) and/or thrombocytopenia within one day of admission.
RESULTS: TAFIa and TAFI levels showed the largest decrease on days one and two, respectively, with a progressive increase thereafter. Overall, 11 patients developed coagulopathy. No statistically significant differences were found for TAFI levels between the two groups. For TAFIa, however, coagulopathic patients experienced significantly lower levels on admission and on days six to eight (all p<0.05). Statistically significant correlations were found between TAFIa level on admission and the amount of packed red blood cells (p=0.011; Spearman's correlation coefficient=-0.5) and fresh frozen plasma (p=0.044; Spearman's correlation coefficient=-0.405) transfused within the initial 24hours.
CONCLUSION: Depletion of TAFIa may contribute to the development of trauma-induced coagulopathy.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23174621     DOI: 10.1016/j.thromres.2012.11.005

Source DB:  PubMed          Journal:  Thromb Res        ISSN: 0049-3848            Impact factor:   3.944


  4 in total

1.  Thromboelastography defines late hypercoagulability after TBI: a pilot study.

Authors:  Allie M Massaro; Sean Doerfler; Kelsey Nawalinski; Bernard Michel; Nicolette Driscoll; Connie Ju; Hiren Patel; Francis Quattrone; Suzanne Frangos; Eileen Maloney-Wilensky; Michael Sean Grady; Sherman C Stein; Scott E Kasner; Monisha A Kumar
Journal:  Neurocrit Care       Date:  2015-02       Impact factor: 3.210

2.  The hyperfibrinolytic phenotype is the most lethal and resource intense presentation of fibrinolysis in massive transfusion patients.

Authors:  John R Taylor; Erin E Fox; John B Holcomb; Sandro Rizoli; Kenji Inaba; Martin A Schreiber; Karen Brasel; Thomas M Scalea; Charles E Wade; Eileen Bulger; Bryan A Cotton
Journal:  J Trauma Acute Care Surg       Date:  2018-01       Impact factor: 3.313

3.  Post-Traumatic Sepsis Is Associated with Increased C5a and Decreased TAFI Levels.

Authors:  Jan Tilmann Vollrath; Ingo Marzi; Anna Herminghaus; Thomas Lustenberger; Borna Relja
Journal:  J Clin Med       Date:  2020-04-24       Impact factor: 4.241

4.  Fibrinolytic system activation immediately following trauma was quickly and intensely suppressed in a rat model of severe blunt trauma.

Authors:  Mineji Hayakawa; Takumi Tsuchida; Yoshinori Honma; Asumi Mizugaki; Takayoshi Ooyasu; Tomonao Yoshida; Tomoyo Saito; Kenichi Katabami; Takeshi Wada; Kunihiko Maekawa
Journal:  Sci Rep       Date:  2021-10-13       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.